.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstract Talk
AT 54

Development of an economically viable vaccine for CCHF virus

Appointment

Date: 6th May 2023

Time: 04:30 p.m. – 04:45 p.m.

Talk time: 10 Min.

Discussion time: 5 Min.

Location / Stream:

Sala Koncertowa

Session

Vaccines II

Topics

Immune response to virus infection
Vaccines

Authors

Dr. Mine Aksular (Oxford / GB), Cassandra Rigby (Oxford / GB), Dr. Adam Chambers (Oxford / GB), Olga Lissina (Oxford / GB), Durva Sevak (Oxford / GB), Emma Kennedy (Salisbury / GB), Dr. Stuart Dowall (Salisbury / GB), Professor Roger Hewson (Salisbury / GB), Marta Ulaszewska (Oxford / GB), Professor Teresa Lambe (Oxford / GB), Professor Linda King (Oxford / GB), Professor Robert Possee (Oxford / GB)